Therapeutic effects of trans-3-methoxy-β-nitrostyrene in rat model of monocrotaline-induced pulmonary hypertension
Abstract
Purpose: We examined the therapeutic effects of the soluble guanylate cyclase stimulator, trans-3-methoxy-β-nitrostyrene (T3MN), on monocrotaline (MCT)-induced pulmonary hypertension (PH) in rats.
Experimental approach: Four weeks following subcutaneous MCT (60 mg/kg) injection, Male Wistar rats were orally treated for two weeks with sildenafil (10 mg/kg/day, MCT-SILD group), T3MN at 25, 50, and 75 mg/kg/day (MCT-T3MN75 group) or with its vehicle (MCT-V group). Control (CNT) rats received only MCT vehicle at Day 0 (D0). All experimental procedures were performed on D43, except for the echodopplercardiography analysis which was performed in D42 in rats from the CNT, MCT-V, MCT-T3MN75 and MCT-SILD groups.
Key results: Compared to CNT rats, MCT-V rats showed significant (1) increase in right ventricle (RV) free wall thickness and Fulton index, (2) decreases of RV stroke volume, pulmonary artery acceleration time (PAAT), PAAT/time of ejection ratio, tricuspid annular plane systolic excursion and velocity-time integral, (3) increase in RV systolic pressure, (4) increase in both pulmonary fibrosis and wall thickness of pulmonary arterioles, and (5) endothelial dysfunction. All these morphometric, invasive hemodynamic, vascular reactivity and pulmonary remodeling changes were significantly and dose-dependently reduced by T3MN. Indeed, changes in hemodynamic parameters recorded by echodopplercardiography were reversed in the MCT-T3MN75 group.
Conclusion: T3MN treatment reversed…
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.